Enhanced and Enduring Protection against Tuberculosis by Recombinant BCG-Ag85C and Its Association with Modulation of Cytokine Profile in Lung
Ruchi Jain, Bappaditya Dey, Neeraj Dhar et al. · 2008
Read Enhanced and Enduring Protection against Tuberculosis by Recombinant BCG-Ag85C and Its Association with Modulation of Cytokine Profile in Lung by Ruchi Jain, Bappaditya Dey, Neeraj Dhar et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0003869.txt.
Description
Ruchi Jain, Bappaditya Dey, Neeraj Dhar, and colleagues published this vaccine study in PLOS ONE in 2008. The BCG vaccine protects against tuberculosis unevenly, with efficacy from zero to eighty percent against adult disease. Better vaccine candidates are needed. One route is recombinant BCG that overproduces strong antigens of the TB bacterium.
The team built a recombinant BCG expressing the antigen Ag85C. It gave enhanced and enduring protection against tuberculosis in their tests. The stronger protection was associated with a changed cytokine profile in the lung, linking the vaccine's effect to the local immune mix. A stronger first shot could protect more of those at risk.
Catalog record
| CREATOR | Ruchi Jain, Bappaditya Dey, Neeraj Dhar et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003869